Abstract:Background: Pleural effusion is commonly observed in patients with advanced lung cancer and its molecular profiling has not been fully investigated. Cell-free (cf) DNA or RNA isolated from cancer patient’s plasma has allowed noninvasive tumor genome analysis, however, there are few study of detection and characterization of cfDNA or cfRNA in pleural effusions and its application in cancer patient treatment. Here we reported the utilization of cell free total nucleic acid (cfTNA) isolated from pleural fluid of late stage lung cancer patient with Next-generation sequencing (NGS) liquid biopsy assay-Oncomine™ Lung cfTNA Assay. The assay simultaneously query about 168 hotspots across ALK, BRAF, EGFR, ERBB2, KRAS, MAP2K1, MET, NRAS, PIK3CA, ROS1, and TP53, CNV (MET), gene fusions (ALK, RET, ROS1) as well as MET exon 14 skipping which have been frequently identified in NSCLC. A comprehensive study of these mutations provides information for therapy decision, disease monitor as well as new drug development. Methods: Ten paired cfTNA were isolated from plural fluid of Non-Small Cell Lung Cancer (NSCLC) subjects, and their matched tumor TNA were extracted from formalin-fixed paraffin-embedded (FFPE) cell pellet collected from same plural fluid. Libraries were prepared using Oncomine Lung Cell-Free Total Nucleic Acid Research Assay and sequenced with Ion S5 Sequencing instrument. Data were analyzed using Ion Reporter 5.6. Results: All cfTNA have been isolated from twenty patient pleural fluid (yield range is 41-1227 ng from 4ml fluid). Bioanalyzer profile of these cfTNA verified the fragmentation pattern, which is similar to cfTNA isolated from plasma. 20ng of cfTNA were tested with Oncomine™ cfDNA Lung assay test, matched somatic variants were detected at a frequency between 6.4% to 54.3% in cfDNA and between 1.2% to 67.6% in corresponding DNA isolated from FFPE. Conclusions: Oncomine™ Lung cfTNA research assay provided an easy, quick and reliable solution in detecting molecular profile using cfTNA isolated from pleural fluid. Molecular analysis of pleural fluid can be used in clinical practice for treatment of late stage cancer patients with pleural fluid. Legal entity responsible for the study: Shanghai Chest Hospital. Funding: Has not received any funding. Disclosure: All authors have declared no conflicts of interest.

Analysis of Deletion of 3p and 9p in Human Lung Cancer

Deletion of P16 gene exon 2 in bronchofibroscopic brush-off cells of human lung carcinoma

Detection of chromosome number abnormalities in lung cancer by fluorescence in situ hybridization

Research of Loss of Heterozygaity on Chromosome 3p in Non-Small Cell Lung Cancer

Application of Next Generation Sequencing in Pleural Effusion Molecular Profiling Using Oncomine™ Lung Cell-Free Total Nucleic Acid Research Assay.

Detailed Deletion Mapping of Chromosome 9p21–22 in Nasopharyngeal Carcinoma

Liquid Biopsies Using Pleural Effusion-Derived Exosomal DNA in Advanced Lung Adenocarcinoma.

Data from Homozygous Deletions and Chromosome Amplifications in Human Lung Carcinomas Revealed by Single Nucleotide Polymorphism Array Analysis

Detection of EGFR Gene Mutation Status from Pleural Effusions and Other Body Fluid Specimens in Patients with Lung Adenocarcinoma

A Case‐control Analysis of Lymphocytic Chromosome 9 Aberrations in Lung Cancer

Specific Deletions of Chromosomes 3p, 5q, 13q, and 21q among Patients with G2 Grade of Non-Small Cell Lung Cancer

Surfactant Protein A Gene Deletion and Prognostics for Patients with Stage I Non–Small Cell Lung Cancer

Comparative study on the mutation spectrum of tissue DNA and blood ctDNA in patients with non-small cell lung cancer

DNA Methylation of Tumor Suppressor Genes Located on Chromosome 3p in Non-small Cell Lung Cancer

[Differential Analysis of Two-Dimension Gel Electrophoresis Profiles of Human Lung Squamous Carcinoma and Tumor-Adjacent Tissue].

Correlation of microsatellite alterations on chromosome 9 and oncogenesis,metastasis in NSCLC

Simultaneous in Situ Detection of Protein Expression of Multiple Tumor Markers of Circulating Tumor Cells and Heteroploid of Chromosome 8 in Primary Lung Cancer

[Fluorescence in Situ Hybridization Combined with Cytomorphology for the Detection of Lung Cancer in Bronchial Brushing Specimens].

Genomic Alterations in Lung Adenocarcinomas Detected by Multicolor Fluorescence in Situ Hybridization and Comparative Genomic Hybridization

The significance of FHIT gene detection for the diagnosis of lung cancer in transbronchial biopsy tissue samples and sputum samples

1P19q Codeletion and RET Rearrangements in Small Cell Lung Cancer.